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Trauma resuscitation paradigms have changed considerably over the last twenty years. Originally, the goal was to
normalize a blood pressure as quickly as possible. Large volume crystalloid resuscitation was used to accomplish
this. Standard therapy was that any patient with suspected bleeding received a two liter crystalloid bolus as initial
therapy. It was often repeated and blood transfusion therapy was used relatively late. Fresh frozen plasma and
platelets were also used relatively late, often after patients had received ten units of red cells. Dilutional anemia
was relatively common. Patients with large volume blood loss often died from what was termed, “the bloody
vicious cycle,” of hypothermia, acidosis and coagulopathy.
Commentary
Trauma resuscitation paradigms have changed consider-
ably over the last twenty years. Originally, the goal was
to normalize a blood pressure as quickly as possible.
Large volume crystalloid resuscitation was used to
accomplish this. Standard therapy was that any patient
with suspected bleeding received a two liter crystalloid
bolus as initial therapy. It was often repeated and blood
transfusion therapy was used relatively late. Fresh frozen
plasma and platelets were also used relatively late, often
after patients had received ten units of red cells. Dilu-
tional anemia was relatively common. Patients with
large volume blood loss often died from what was
termed, “the bloody vicious cycle,” of hypothermia,
acidosis and coagulopathy. Some of this was almost cer-
tainly iatrogenic from our resuscitation strategies [1].
The epidemic of urban violence that plagued large
American cities in the late 1980’s and early 1990’s focused
trauma surgeons on rethinking how we cared for serious
injury. Damage control techniques were described and
were incorporated into clinical practice [2]. In addition,
use of deliberate hypotension was proven to be an effective
strategy in the two randomized prospective trails that have
been conducted in humans [3,4]. This is now widely prac-
ticed in many trauma centers, particularly in patients
under the age of sixty-five years who do not have conco-
mitant brain or spinal cord injuries.
Hemostatic resuscitation has also recently become a
popular form of transfusion therapy. The concept of giving
plasma and platelets early along with red cells in an
attempt to closely approximate whole blood makes a lot of
sense. In fact, when we reviewed blood usage at the Shock
Trauma Center in the year 2000, massively transfused
patients ultimately received a unit of plasma for every unit
of blood that was transfused [5]. It made a lot of sense
that giving FFP earlier would be beneficial. Clinical prac-
tice evolved even though there was a paucity of data. The
military adopted hemostatic resuscitation. Data from the
war certainly supports its use [6]. Civilian trauma centers
followed. The new resuscitative paradigm has become to
allow a systolic blood pressure to be around 80 mmHg, to
limit crystalloid resuscitation, and use blood, FFP and pla-
telets in a one to one to one ratio.
There are a number of recent civilian studies that com-
ment on the efficacy of hemostatic resuscitation. Some
have been done at single institutions [7,8]. Holcomb et al,
however, reported a multicenter trial in sixteen U.S. level
one trauma centers [9]. Patients who received high FFP
and high platelet transfusion therapy had a significantly
increased survival. In addition, those who died were signif-
icantly less likely to die from truncal hemorrhage and
more likely to die from concomitant brain injury. That
contrasts with our large single institution series that
showed no difference in survival when a high FFP and red
cell ratio was used [10]. The current paper [11] supports
our work as it showed no difference in survival. How then
can we reconcile these differences?
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hospital resuscitation strategies and transportation strate-
gies. There can be little question that care provided in
the prehospital phase has impact on long term outcome.
Strategies such as “stay and play” vs. “load and go” may
have some influence on survival. Some prehospital sys-
tems utilize physicians at the scene and en route to the
trauma center. It is unclear whether this changes out-
come but it almost certainly changes the process of care
in the prehospital arena. Resuscitation strategies vary
from institution to institution and from practitioner to
practitioner. All of these may affect outcome. Yet, none
of these are analyzed in any of the manuscripts published
so far. These differences almost certainly persist after
trauma center admission. Death after trauma can be
from so many factors. Is it possible one change can affect
outcome so markedly? It is hard to know the answer.
In the current manuscript, the authors changed their
transfusion therapy and they then surveyed the time
periods before and after these changes were made. 2004
was excluded as hemostatic resuscitation was introduced
that year. They used an elegant statistical analysis to
demonstrate that mortality did not change. A number of
issues must be kept in mind when reading this manu-
script. There is no description of cause of death. In fact,
the same phenomenon may have occurred as described
by Holcomb et al. Perhaps the cause of death changed
and patients in the later group died from brain injury as
opposed to exsanguination, or the affects of hemorrhage.
In addition, no hemodynamic data is presented. While
Injury Severity Score (ISS) is a good measure of ana-
tomic injury, it is not a measure of the patient’s physiol-
ogy. Patients with multiple bony injury had the same
ISS as did patients with severe torso injury. Yet, the rate
of bleeding may be different. In fact, there was a statisti-
cally significant difference in the transfusions given in
the first six hours when the early group was compared
to the hemostatic resuscitation period.
Patients in the hemostatic resuscitation period got 20
units of blood in the first six hours after admission as
opposed to 12 units during the earlier time period
before changes were made. As the indication for trans-
fusion did not apparently change, one might conclude
that those patients were bleeding more quickly, and in
fact were physiologically less stable. In addition, it
would appear to me that virtually all of the blood was
given early. Total transfusions were the same as the
transfusions in the first six hours in the hemostatic
resuscitation time period, and went up only minimally
in the first time period. This would be different than
transfusion practices in many trauma centers. The vast
majority of patients presented in this series have blunt
trauma. Many of them will have bled from bony injuries.
This can certainly be impressive but it is different from
true exsanguination from a grade V liver injury or sig-
nificant intrathoracic injury. A better analysis might be
to look at units of blood per hour as opposed to units
of blood over a particular period of time.
There is little question that hemostatic resuscitation has
changed the way that many trauma centers practice.
While I have some concerns about this manuscript [11],
this is clearly important work and is one of the few series
that fails to demonstrate survival advantage from this new
type of transfusion therapy. In fact, the authors are exactly
correct when they conclude “prospective studies addres-
sing the effect of various means of hemostatic controlled
resuscitation in trauma patients presenting bleeding
requiring transfusions are desperately needed.” It is not
until a true prospective randomized trail is undertaken,
that we will really begin to start to answer the question of
how much FFP is wise and when it ought to be utilized.
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